Celestial Labs, leading developer of biopharmaceuticals and industrial enzymes, has acquired the channel partnership of Microsoft to strengthen its ERP business.

The tender offer, which was put forward by Sun Pharmaceutical Industries

Karvy Stock Broking Limited has maintained ‘Buy’ rating on Ranbaxy Laboratories stock with an intraday target of Rs 430.

Shares of Ranbaxy Laboratories Ltd witnessed the biggest fall in past

Indiabulls Securities Ltd has maintained a ‘Hold’ rating on Dr Reddy’s